Author Archives: admin

The Weekly Summary

September 11th – September 17th                                 2017

Posted in - The Weekly Summary | Leave a comment

How the FDA regulates compounding pharmacies

April 5, 2015- Interviewed by Steven E. Greer, MD Few people knew what a compounding pharmacy was until a meningitis outbreak traced to the

Posted in - Policy, FDA | 1 Comment

Is Vitamin-D deficiency overdiagnosed?

November 8, 2016- Interviewed by Steven E. Greer, MD We interviewed JoAnn E. Manson, MD, DrPH, Chief, Division of Preventive Medicine, Brigham

Posted in - NEJM, - Policy, CDC, Diabetes and endocrinology, FDA, Harvard, Primary care medicine | Leave a comment

The NIH has turned into a source of welfare for bloated universities

September 12, 2017- Science reports, “President Donald Trump’s administration has brought a long-simmering debate over how the U.S. government supports university research

Posted in - Opinion, Congress, NIH | 1 Comment

What Steve Jobs would have invented if he had lived longer

Update January 29, 2014- Apple posted Q4 earnings so big that they are incomprehensible.

Posted in - Medical Devices, - Opinion | Leave a comment

An emerging safety problem for TAVR patients

March 16, 2017- produced and interviewed by Steven E. Greer, MD We interviewed William O’Neill, MD, one of the first to implant a Transcatheter Aortic Valve Replacement (TAVR) valve. The products have been approved by the FDA for several years, … Continue reading

Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA | Leave a comment

The Weekly Summary

September 4th – September 10th                                 2017 In general news, one week after the worst disaster to hit thus U.S., which was Hurricane Harvey in Texas, Hurricane Irma hit Florida. However, the excessive TV hype did not materialize as the storm … Continue reading

Posted in - The Weekly Summary | Leave a comment

The Healthcare Channel hits 10

 February 3, 2017- by Steven E. Greer, MD I don’t recall the exact date, but it was sometime during the summer of 2006, when I was daydreaming

Posted in - Opinion | 1 Comment

What 1982’s Blade Runner got right about 2019

September 3, 2017- by Steven E. Greer, MD I watched again the 1982 classic Blade Runner. Directed by Ridley Scott and starring Harrison Ford,

Posted in - Opinion, - Reviews, books, devices, Genetics, Geriatrics, Obstetrics and Gynecology, Oncology, Ophthalmology | Leave a comment

Maybe my brain was spared

July 26, 2017- by Steven E. Greer, MD Last week, I sat next to an Ohio State University offensive lineman while attending a Roger Waters

Posted in - JAMA, - Reviews, books, devices, Neurology, Neurosurgery, Ohio State, Ohio State | 1 Comment

Current surgical weight loss therapies

January 24, 2014- Interviewed by Steven E. Greer, MD Erik Dutson, MD, weight loss surgeon at UCLA, explains why his medical center does not implant the Lap-Band,

Posted in - Medical Devices, Bariatric surgery, General surgery, UCLA | Leave a comment

The bionic pancreas data

July 2, 2014- Interviewed by Steven E. Greer, MD The New England Journal of Medicine recently published the early clinical data on the “bionic pancreas”

Posted in - Medical Devices, - NEJM, Boston University, Diabetes and endocrinology | Leave a comment

Changes in plastic surgery training programs

March 3, 2015- Interviewed by Steven E. Greer, MD In Part 1 of our interview with the new Chairman of Plastic Surgery at NYU, Eduardo Rodriguez,

Posted in - Policy, NYU, Plastic surgery | Leave a comment

The new CDC guidelines for prescribing opioid pain pills

June 1, 2016- Interviewed by Steven E. Greer, MD Pain pill prescriptions have quadrupled since the 1990’s as drug companies stepped up marketing and funded

Posted in - JAMA, - NEJM, - Pharma, CDC, Emergency medicine, General surgery, Oncology, Psychology Psychiatry, Rehab, Spine surgery, Sports medicine | Leave a comment

The Deans of Johns Hopkins and Miami discuss ACO’s

February 28, 2011- By Steven E Greer, MD Dean Miller of Johns Hopkins and Dean Goldschmidt of Miami discuss accountable care organizations,

Posted in - Policy, CMS, Johns Hopkins | Leave a comment

The Biggest Healthcare Stories of 2016

December 26, 2016- by Steven E. Greer, MD for The Healthcare Channel Policy changes dominated the 2016 year in healthcare news. There were few important new drug

Posted in - Biotech, - Generics, - Medical Devices, - Opinion, - Pharma, - Policy, - The Weekly Summary, CMS, FDA | Leave a comment

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

February 27, 2017- interviewed by Steven E. Greer, MD We interviewed Joaquim Bellmunt, MD, PhD, the Director of the Bladder Cancer Center at Dana-Farber,

Posted in - Biotech, - NEJM, - Pharma, Harvard, Oncology | Leave a comment

CDER Director Janet Woodcock on new drug safety strategies

November 16, 2010- by Steven E. Greer, MD We interviewed Dr. Janet Woodcock, long-time Director of CDER, the FDA center responsible

Posted in - Pharma, FDA | Leave a comment

The Who’s Teen Cancer Lounge at Sloan Kettering opens

March 18, 2016- by Steven E. Greer MD The Memorial Sloan Kettering Cancer Center held a press day for its new teen lounge

Posted in Memorial Sloan-Kettering, Oncology | Leave a comment

The super shady methods of pricing generic drugs in America: case study- Sildenafil

May 15, 2016- by Steven E. Greer, MD The last I read, Teva and Mylan were not supposed to launch their approved generic of Viagra (sildenafil)

Posted in - Generics, - Opinion, - Pharma, CMS, Congress, FDA | Leave a comment